GHB formulation and method for its manufacture
The present application relates to GHB formulations and methods for manufacturing the same.
1. A formulation of gamma-hydroxybutyrate comprising:
a plurality of immediate release particles comprising gamma-hydroxybutyrate;
a plurality of modified release particles comprising gamma-hydroxybutyrate;
a viscosity enhancing agent; and
an acid;
wherein the viscosity enhancing agent and the acid are separate from the immediate release particles and the modified release particles.
2. The formulation of claim 1 , wherein the viscosity enhancing agent is selected from the group consisting of xanthan gum, microcrystalline cellulose, hydroxyethyl cellulose, hydroxypropylmethyl cellulose, carboxymethylcellulose sodium, hydroxypropyl cellulose and mixtures thereof.
3. The formulation of claim 1 , wherein the acid is selected from the group consisting of malic acid, citric acid, tartaric acid, boric acid, maleic acid, phosphoric acid, and benzoic acid.
4. The formulation of claim 1 , wherein the formulation further comprises a lubricant selected from the group consisting of magnesium stearate, stearic acid, calcium stearate, hydrogenated castor oil, hydrogenated vegetable oil, light mineral oil, mineral oil, polyethylene glycol, sodium benzoate, sodium stearyl fumarate, and zinc stearate.
5. The formulation of claim 4 , wherein the lubricant is magnesium stearate.
6. The formulation of claim 1 , wherein the formulation comprises an amount of gamma-hydroxybutyrate equivalent to from 4.0 g to 12.0 g of sodium gamma-hydroxybutyrate.
7. The formulation of claim 1 , wherein the formulation comprises an amount of gamma-hydroxybutyrate equivalent to about 4.0 g, about 6 g, about 7.5 g or about 9 g of sodium gamma-hydroxybutyrate.
8. The formulation of claim 1 , wherein the formulation comprises an amount of gamma-hydroxybutyrate equivalent to about 6 g of sodium gamma-hydroxybutyrate.
9. The formulation of claim 1 , wherein the formulation comprises an amount of gamma-hydroxybutyrate equivalent to about 7.5 g of sodium gamma-hydroxybutyrate.
10. The formulation of claim 1 , wherein the formulation comprises an amount of gamma-hydroxybutyrate equivalent to about 9 g of sodium gamma-hydroxybutyrate.
11. The formulation of claim 1 , wherein 8 h after administration of the formulation provides a blood concentration ranging from 10 mg/L to about 40 mg/mL.
12. The formulation of claim 1 , wherein 8 h after administration of the formulation provides a blood concentration ranging from 15 mg/L to about 30 mg/mL.
13. The formulation of claim 1 , wherein the formulation is a multiparticulate composition.
14. A unit dose comprising a formulation of gamma-hydroxybutyrate,
wherein the formulation comprises:
a plurality of immediate release particles comprising gamma-hydroxybutyrate;
a plurality of modified release particles comprising gamma-hydroxybutyrate;
a viscosity enhancing agent; and
an acid;
wherein the viscosity enhancing agent and the acid are separate from the immediate release particles and the modified release particles.
15. The unit dose of claim 14 , wherein the viscosity enhancing agent is selected from the group consisting of xanthan gum, microcrystalline cellulose, hydroxyethyl cellulose, hydroxypropylmethyl cellulose, carboxymethylcellulose sodium, hydroxypropyl cellulose and mixtures thereof.
16. The unit dose of claim 14 , wherein the acid is selected from the group consisting of malic acid, citric acid, tartaric acid, boric acid, maleic acid, phosphoric acid, and benzoic acid.
17. The unit dose of claim 14 , wherein the formulation further comprises a lubricant selected from the group consisting of magnesium stearate, stearic acid, calcium stearate, hydrogenated castor oil, hydrogenated vegetable oil, light mineral oil, mineral oil, polyethylene glycol, sodium benzoate, sodium stearyl fumarate, and zinc stearate.
18. The unit dose of claim 17 , wherein the lubricant is magnesium stearate.
19. The unit dose of claim 14 , wherein 8 h after administration of the formulation provides a blood concentration ranging from 15 mg/L to about 30 mg/mL.
20. The unit dose of claim 14 , wherein the unit dose comprises an amount of gamma-hydroxybutyrate equivalent to from 4.0 g to 12.0 g of sodium gamma-hydroxybutyrate.
21. The unit dose of claim 14 , wherein unit dose contains an amount of gamma-hydroxybutyrate equivalent to about 6 g of sodium gamma-hydroxybutyrate.
22. The unit dose of claim 14 , wherein unit dose contains an amount of gamma-hydroxybutyrate equivalent to about 7.5 g of sodium gamma-hydroxybutyrate.
23. The unit dose of claim 14 , wherein unit dose contains an amount of gamma-hydroxybutyrate equivalent to about 9 g of sodium gamma-hydroxybutyrate.
24. The unit dose of claim 14 , wherein the unit dose is a sachet.